{"id":"https://openalex.org/W4393093751","doi":"https://doi.org/10.1158/1538-7445.am2024-5724","title":"Abstract 5724: Preclinical evaluation of a novel CHK1 inhibitor encapsulated within the liposome, SMP-3124, for the treatment of solid cancer","display_name":"Abstract 5724: Preclinical evaluation of a novel CHK1 inhibitor encapsulated within the liposome, SMP-3124, for the treatment of solid cancer","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393093751","doi":"https://doi.org/10.1158/1538-7445.am2024-5724"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-5724","doi":"https://doi.org/10.1158/1538-7445.am2024-5724","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-5724","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078848738","display_name":"Yuka Kumagai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuka Kumagai","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021010053","display_name":"Ryosaku Inagaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryosaku Inagaki","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043657069","display_name":"Kana Shimizu","orcid":"https://orcid.org/0000-0001-6452-9091","observed_orcids":["https://orcid.org/0000-0001-6452-9091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kana Shimizu","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wataru Hirose","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wataru Hirose","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Naoaki Shimada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoaki Shimada","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103346932","display_name":"Kento Hayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kento Hayashi","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009791648","display_name":"Yoshiko Fukuoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiko Fukuoka","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021837954","display_name":"Makoto Matsuoka","orcid":"https://orcid.org/0000-0002-8167-7886","observed_orcids":["https://orcid.org/0000-0002-8167-7886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Makoto Matsuoka","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018087912","display_name":"Seiji Kamioka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seiji Kamioka","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103637365","display_name":"Hitoshi Ban","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hitoshi Ban","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112241470","display_name":"Hiroki Umehara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroki Umehara","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001035808","display_name":"Yusuke Sawayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusuke Sawayama","raw_affiliation_strings":["1Sumitomo Pharma Co., Ltd, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sumitomo Pharma Co., Ltd, Osaka, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"5724","last_page":"5724"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.42500001192092896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.42500001192092896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.3700999915599823,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.03420000150799751,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chk1-inhibitor","display_name":"CHK1 inhibitor","score":0.9359999895095825},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.9459999799728394},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.7879999876022339},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9819999933242798},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7149999737739563},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/gemcitabine-combination","display_name":"gemcitabine combination","score":0.8429999947547913},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7409999966621399},{"id":"https://openalex.org/keywords/peritoneal-metastases","display_name":"peritoneal carcinomatosis","score":0.7770000100135803},{"id":"https://openalex.org/keywords/orthotopic-model","display_name":"orthotopic model","score":0.7310000061988831},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5410000085830688},{"id":"https://openalex.org/keywords/s-phase-arrest","display_name":"S phase arrest","score":0.6850000023841858},{"id":"https://openalex.org/keywords/anticancer-drug-toxicity","display_name":"anticancer drug toxicity","score":0.5270000100135803},{"id":"https://openalex.org/keywords/investigational-new-drug-application","display_name":"Investigational New Drug application","score":0.8309999704360962},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5994940400123596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4754195809364319},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.46684110164642334},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.46038341522216797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39855021238327026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2720562815666199},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2659825086593628},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10637614130973816}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-5724","doi":"https://doi.org/10.1158/1538-7445.am2024-5724","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-5724","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7162516310","https://openalex.org/W3131590322","https://openalex.org/W2803556357","https://openalex.org/W2488349910","https://openalex.org/W2803611844","https://openalex.org/W2066967559","https://openalex.org/W2036522505","https://openalex.org/W2083101590","https://openalex.org/W2141306016","https://openalex.org/W2887679346"],"abstract_inverted_index":{"Abstract":[0],"Checkpoint":[1],"kinase":[2,8],"1":[3,304],"(CHK1)":[4],"is":[5,27,68],"a":[6,11,94,158,275],"serine/threonine":[7],"which":[9,139],"plays":[10],"critical":[12],"role":[13],"for":[14,71,284,297],"DNA":[15,36,45],"damage":[16],"responses":[17,113],"(DDR)":[18],"throughout":[19],"the":[20,57,130,166,175,179,281,285,294],"cell":[21,84,91],"cycle":[22],"in":[23,34,44,86,98,103,114,148,152,178,181,191,207,224,244],"human":[24,215],"cells.":[25,218],"CHK1":[26,67,76,134,162,277],"mainly":[28],"activated":[29],"by":[30,39,233],"replication":[31],"stress":[32],"resulting":[33],"single-stranded":[35],"breaks":[37],"induced":[38,232],"chemotherapeutic":[40],"agents":[41],"or":[42],"mutations":[43],"repair":[46],"related":[47],"genes.":[48],"These":[49],"kinds":[50],"of":[51,89,96,108,125,189,274,287,293],"stresses":[52],"are":[53,101,122,236],"reported":[54],"to":[55,143,174,238],"increase":[56],"dependency":[58],"on":[59],"DDR":[60],"pathway":[61,100],"molecule":[62],"including":[63],"CHK1.":[64],"Therefore,":[65],"targeting":[66],"promising":[69],"strategy":[70],"drug":[72,141,146,242],"discovery.":[73],"In":[74,200],"fact,":[75],"inhibition":[77],"induces":[78],"S":[79],"phase":[80],"arrest":[81],"and":[82,117,150,160,211],"inhibits":[83],"growth":[85,223],"wide":[87],"range":[88],"cancer":[90,217,289],"lines.":[92],"Recently,":[93],"number":[95],"drugs":[97],"this":[99],"tested":[102],"clinical":[104,112],"trials.":[105],"Although":[106],"some":[107],"them":[109],"showed":[110,169,203],"obvious":[111],"both":[115,208],"monotherapy":[116],"combination":[118,225],"therapy,":[119],"their":[120,126],"efficacies":[121],"limited":[123],"because":[124],"toxicities.":[127],"To":[128],"maximize":[129],"efficacy,":[131],"we":[132,155],"utilized":[133],"inhibitor":[135,163,278],"with":[136,226],"liposomal":[137,176],"formulation":[138],"changes":[140],"distribution":[142],"achieve":[144],"longer":[145],"retention":[147],"plasma":[149],"accumulation":[151,177],"tumor.":[153],"Here,":[154],"generated":[156],"SMP-3124,":[157,283],"novel":[159,276],"selective":[161],"encapsulated":[164,279],"within":[165,280],"liposome.":[167],"SMP-3124":[168,190,202,219],"durable":[170],"pharmacodynamic":[171],"response":[172],"due":[173],"tumor":[180,222],"xenograft":[182],"model.":[183],"We":[184,235],"confirmed":[185],"potent":[186],"anti-tumor":[187],"activities":[188],"multiple":[192],"subcutaneous":[193],"xenografted":[194],"models":[195],"without":[196,228],"severe":[197],"side":[198],"effects.":[199],"addition,":[201],"prolonged":[204],"overall":[205],"survival":[206],"peritoneal":[209],"dissemination":[210],"orthotopic":[212],"model":[213],"using":[214],"ovarian":[216],"synergistically":[220],"inhibited":[221],"gemcitabine":[227],"additional":[229],"hematological":[230],"toxicities":[231],"gemcitabine.":[234],"planning":[237],"an":[239],"investigational":[240],"new":[241],"application":[243],"2024.":[245],"Citation":[246],"Format:":[247],"Yuka":[248],"Kumagai,":[249],"Ryosaku":[250],"Inagaki,":[251],"Kana":[252],"Shimizu,":[253],"Wataru":[254],"Hirose,":[255],"Naoaki":[256],"Shimada,":[257],"Kento":[258],"Hayashi,":[259],"Yoshiko":[260],"Fukuoka,":[261],"Makoto":[262],"Matsuoka,":[263],"Seiji":[264],"Kamioka,":[265],"Hitoshi":[266],"Ban,":[267],"Hiroki":[268],"Umehara,":[269],"Yusuke":[270],"Sawayama.":[271],"Preclinical":[272],"evaluation":[273],"liposome,":[282],"treatment":[286],"solid":[288],"[abstract].":[290],"In:":[291],"Proceedings":[292],"American":[295],"Association":[296],"Cancer":[298,316],"Research":[299],"Annual":[300],"Meeting":[301],"2024;":[302],"Part":[303],"(Regular":[305],"Abstracts);":[306],"2024":[307],"Apr":[308],"5-10;":[309],"San":[310],"Diego,":[311],"CA.":[312],"Philadelphia":[313],"(PA):":[314],"AACR;":[315],"Res":[317],"2024;84(6_Suppl):Abstract":[318],"nr":[319],"5724.":[320]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-03-23T00:00:00"}